Aberrant p53 Immunostaining in Barrett’s Esophagus Predicts Neoplastic Progression: Systematic Review and Meta-Analyses

Detection of Mutations in Barrett’s Esophagus Before Progression to High-Grade Dysplasia or Adenocarcinoma

(2018) Matthew D. Stachler et al.   GASTROENTEROLOGY

Efficacy and safety outcomes of multimodal endoscopic eradication therapy in Barrett’s esophagus-related neoplasia: a systematic review and pooled analysis

(2017) Madhav Desai et al.   GASTROINTESTINAL ENDOSCOPY

Diagnosis and risk stratification of Barrett’s dysplasia by flow cytometric DNA analysis of paraffin-embedded tissue

(2017) Won-Tak Choi et al.   GUT

p53 protein accumulation predicts malignant progression in Barrett's metaplasia: a prospective study of 275 patients

(2017) Mamoun Younes et al.   HISTOPATHOLOGY

Use of immunohistochemical biomarkers as independent predictor of neoplastic progression in Barrett's oesophagus surveillance: A systematic review and meta-analysis

(2017) Vincent T. Janmaat et al.   PLoS One

Aneuploidy and high expression of p53 and Ki67 is associated with neoplastic progression in Barrett esophagus

(2017) Marjon Kerkhof et al.   Cancer Biomarkers

Barrett’s Esophagus

(2016) Bita V. Naini et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Diagnosis and Management of Low-Grade Dysplasia in Barrett’s Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association

(2016) Sachin Wani et al.   GASTROENTEROLOGY

ACG Clinical Guideline: Diagnosis and Management of Barrett’s Esophagus

(2015) Nicholas J Shaheen et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Derivation of genetic biomarkers for cancer risk stratification in Barrett’s oesophagus: a prospective cohort study

(2015) Margriet R Timmer et al.   GUT

Expression of p53 predicts risk of prevalent and incident advanced neoplasia in patients with Barrett's esophagus and epithelial changes indefinite for dysplasia

(2015) Bela Horvath et al.   Gastroenterology Report

Aberrant TP53 detected by combining immunohistochemistry and DNA-FISH improves Barrett's esophagus progression prediction: A prospective follow-up study

(2014) Akueni L. Davelaar et al.   GENES CHROMOSOMES & CANCER

Nanoscale markers of esophageal field carcinogenesis: potential implications for esophageal cancer screening

(2013) Vani Konda et al.   ENDOSCOPY

British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus

(2013) Rebecca C Fitzgerald et al.   GUT

Population-Based Study Reveals New Risk-Stratification Biomarker Panel for Barrett's Esophagus

(2012) Elizabeth L. Bird–Lieberman et al.   GASTROENTEROLOGY

The role of endoscopy in Barrett's esophagus and other premalignant conditions of the esophagus

(2012) John A. Evans et al.   GASTROINTESTINAL ENDOSCOPY

Aberrant p53 protein expression is associated with an increased risk of neoplastic progression in patients with Barrett's oesophagus

(2012) Florine Kastelein et al.   GUT

American Gastroenterological Association Technical Review on the Management of Barrett's Esophagus

(2011) Stuart J. Spechler et al.   GASTROENTEROLOGY

Incidence of Adenocarcinoma among Patients with Barrett's Esophagus

(2011) Frederik Hvid-Jensen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Low-Grade Dysplasia in Barrett's Esophagus: Overdiagnosed and Underestimated

(2010) Wouter L Curvers et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Esophageal Adenocarcinoma Incidence: Are We Reaching the Peak?

(2010) H. Pohl et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Novel staining pattern of p53 in Barrett’s dysplasia - the absent pattern

(2010) Philip V Kaye et al.   HISTOPATHOLOGY

A Multicenter, Double-Blinded Validation Study of Methylation Biomarkers for Progression Prediction in Barrett's Esophagus

(2009) Z. Jin et al.   CANCER RESEARCH

Radiofrequency Ablation in Barrett's Esophagus with Dysplasia

(2009) Nicholas J. Shaheen et al.   NEW ENGLAND JOURNAL OF MEDICINE